IRIS PubliCatt

Leone, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.401
NA - Nord America 9.138
AS - Asia 2.393
OC - Oceania 80
SA - Sud America 63
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 8
Totale 22.143
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.041
DE - Germania 4.990
CN - Cina 1.818
SE - Svezia 1.571
UA - Ucraina 1.074
IT - Italia 638
FR - Francia 478
GB - Regno Unito 424
IE - Irlanda 370
PL - Polonia 339
IN - India 229
FI - Finlandia 215
TR - Turchia 152
AU - Australia 69
RU - Federazione Russa 57
CA - Canada 55
CI - Costa d'Avorio 49
BE - Belgio 43
JP - Giappone 41
NL - Olanda 35
ES - Italia 34
MX - Messico 32
BR - Brasile 29
IR - Iran 28
VN - Vietnam 20
AR - Argentina 19
HK - Hong Kong 19
CH - Svizzera 16
RO - Romania 16
ID - Indonesia 12
NO - Norvegia 12
AT - Austria 11
NZ - Nuova Zelanda 11
SG - Singapore 11
GR - Grecia 10
HU - Ungheria 9
CZ - Repubblica Ceca 8
KR - Corea 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
PT - Portogallo 7
BG - Bulgaria 6
CO - Colombia 6
IL - Israele 6
TH - Thailandia 6
HR - Croazia 5
LU - Lussemburgo 5
RS - Serbia 5
BD - Bangladesh 4
BZ - Belize 4
MY - Malesia 4
NP - Nepal 4
TW - Taiwan 4
BY - Bielorussia 3
CR - Costa Rica 3
EE - Estonia 3
LB - Libano 3
LV - Lettonia 3
MK - Macedonia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
IS - Islanda 2
JO - Giordania 2
MA - Marocco 2
PH - Filippine 2
PK - Pakistan 2
SD - Sudan 2
A1 - Anonimo 1
CL - Cile 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
GH - Ghana 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 22.143
Salva come PNG Salva come JPEG
Città #
Chandler 1.609
Jacksonville 699
Ashburn 695
Nanjing 454
San Mateo 451
Dearborn 448
Dublin 360
Ann Arbor 352
Nürnberg 335
Warsaw 314
Woodbridge 270
Houston 269
Wilmington 249
Beijing 207
Milan 190
Hangzhou 182
New York 182
Seattle 182
Nanchang 179
Redwood City 154
Lawrence 148
Izmir 133
Bremen 131
Boston 126
Marseille 120
Munich 116
Los Angeles 112
Fairfield 107
Kunming 101
Lancaster 101
Cattolica 81
Shenyang 79
Zhengzhou 73
University Park 67
Hebei 63
Tianjin 61
Leawood 59
Princeton 57
Mountain View 55
Chicago 54
Guangzhou 51
Abidjan 49
Changsha 48
Hefei 48
Auburn Hills 47
Jiaxing 46
Norwalk 46
Redmond 45
Shanghai 41
Boardman 40
Rome 38
Brussels 37
Pune 36
Cambridge 35
Fremont 34
Jinan 34
Philadelphia 32
Augusta 26
Lanzhou 23
Simi Valley 23
Changchun 21
Detroit 21
Buffalo 19
Chatsworth 19
San Diego 19
San Jose 19
Brisbane 18
Hanoi 17
Wayne 17
Costa Mesa 16
Federal 16
Hong Kong 16
Mexico 16
Tobarra 16
Brooklyn 15
Berlin 14
Helsinki 14
London 14
Ningbo 14
Phoenix 14
Taizhou 14
Indiana 13
San Francisco 13
Ypsilanti 13
Amsterdam 12
Falls Church 12
Toronto 12
Washington 12
Kocaeli 11
Kraków 11
Moscow 11
São Paulo 11
Edinburgh 10
Kish 10
Monmouth Junction 10
Sydney 10
Chengdu 9
Hermosillo 9
Mumbai 9
Verona 9
Totale 10.960
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 1.421
Incidence of acute myeloid leukemia after breast cancer 330
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 296
Factors associated with mortality in bacteremic patients with haematologic malignancies 291
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 225
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 222
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 221
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 218
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 201
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 195
A Novel Route of Transplantation of Human Cord Blood Stem Cells in Preimmune Fetal Sheep: The Intracelomic Cavity 188
A) A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 179
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 174
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 163
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 163
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 161
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 159
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 159
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 158
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 152
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 150
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 148
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 142
Von hippel-lindau disease and erythrocytosis 141
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 139
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 139
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 135
Correlation between paraproteinaemia and viral reactivation after allo-SCT 131
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 130
Why methylation is not a marker predictive of response to hypomethylating agents 130
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 130
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 129
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 129
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 128
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 128
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 127
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 127
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 127
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 127
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 126
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 126
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 126
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 125
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 122
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 122
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 122
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 122
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 122
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 121
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 120
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 119
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 119
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 118
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 118
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 117
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 116
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 115
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 115
The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. 114
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 114
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 113
T lymphocyte subsets and platelet-associated IgG in idiopathic thrombocytopenic purpura: effect of splenectomy. 112
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 111
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 111
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 111
Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype 110
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 110
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 109
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 108
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 108
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 107
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 107
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 106
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 106
Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation 106
Primary plasma cell leukemia followed by testicular plasmacytoma 106
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database 105
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 104
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 104
In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells 104
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 103
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 103
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 103
Non-invasive detection of fetal Rhesus D Status: A comparison between Polymerase Chain Reaction and flow Cytometry 102
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 101
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 101
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 101
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 101
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 100
Iron in Hodgkin's lymphoma 100
Similarities and differences between therapy-related and elderly acute myeloid leukemia 99
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 99
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 99
Epigenetic changes in therapy-related MDS/AML 98
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine 98
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 98
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 98
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 98
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 97
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 97
Totale 14.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.493
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019799 0 0 0 0 0 0 0 0 0 252 309 238
2019/20204.059 659 329 253 297 404 491 360 154 295 267 277 273
2020/20212.596 94 279 64 242 293 211 322 59 286 155 526 65
2021/20222.084 219 240 37 106 138 77 53 345 85 137 283 364
2022/20234.368 520 641 333 725 310 530 225 344 510 46 118 66
2023/20241.884 103 573 87 110 149 387 124 104 102 145 0 0
Totale 22.270